We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-11.4%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$57.4B
AUM Growth
-$7.29B
Cap. Flow
+$861M
Cap. Flow %
1.5%
Top 10 Hldgs %
21.3%
Holding
3,843
New
205
Increased
1,398
Reduced
1,819
Closed
309

Sector Composition

Rank Sector Weight
1 Technology 9.78%
2 Financials 8.85%
3 Healthcare 8.68%
4 Industrials 6.29%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TOO
3326
DELISTED
Teekay Offshore Partners L.P.
TOO
$75K ﹤0.01%
62,239
+17,620
+39% +$32.6K
HD icon
3327
CALL
Home Depot
HD
$350B
$73K ﹤0.01%
67,400
+600
+0.9% +$108K
IID
3328
DELISTED
VOYA INTERNATIONAL HIGH DIVIDEND EQUITY INCOME FUND
IID
$73K ﹤0.01%
14,148
JNCE
3329
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$71K ﹤0.01%
+20,961
New +$97.9K
TLPH icon
3330
Talphera
TLPH
$73.2M
$68K ﹤0.01%
1,475
+725
+97% +$48.5K
NSL
3331
DELISTED
NUVEEN SENIOR INCM FD
NSL
$67K ﹤0.01%
12,136
-3,630
-23% -$21.3K
DF
3332
DELISTED
Dean Foods Company
DF
$67K ﹤0.01%
17,633
+1,837
+12% +$11.1K
UAN icon
3333
CVR Partners
UAN
$1.24B
$66K ﹤0.01%
1,948
-1,067
-35% -$40.4K
GNMK
3334
DELISTED
GenMark Diagnostics, Inc
GNMK
$66K ﹤0.01%
13,550
-5,000
-27% -$26K
GEN
3335
DELISTED
Genesis Healthcare, Inc.
GEN
$65K ﹤0.01%
55,000
PETX
3336
DELISTED
Aratana Therapeutics, Inc.
PETX
$65K ﹤0.01%
+10,650
New +$65K
ADMA icon
3337
ADMA Biologics
ADMA
$2.18B
$64K ﹤0.01%
26,871
+10,610
+65% +$52.5K
MPWR icon
3338
CALL
Monolithic Power Systems
MPWR
$67.9B
$64K ﹤0.01%
17,800
-200
-1% -$23.9K
WTI icon
3339
W&T Offshore
WTI
$577M
$63K ﹤0.01%
15,330
+769
+5% +$4.91K
RNGR icon
3340
Ranger Energy Services
RNGR
$388M
$62K ﹤0.01%
12,000
-500
-4% -$3.59K
KDNY
3341
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$62K ﹤0.01%
4,690
FTR
3342
DELISTED
Frontier Communications Corp.
FTR
$62K ﹤0.01%
26,053
-6,849
-21% -$29K
GPRO icon
3343
GoPro
GPRO
$121M
$61K ﹤0.01%
14,342
-555
-4% -$3.1K
PM icon
3344
PUT
Philip Morris
PM
$290B
$61K ﹤0.01%
+20,000
New +$1.67M
TMQ
3345
Trilogy Metals
TMQ
$670M
$61K ﹤0.01%
+35,240
New +$71.4K
BMY icon
3346
PUT
Bristol-Myers Squibb
BMY
$132B
$59K ﹤0.01%
+20,000
New +$1.07M
DHX icon
3347
DHI Group
DHX
$158M
$57K ﹤0.01%
37,743
-12,595
-25% -$21.8K
SPWH icon
3348
Sportsman's Warehouse
SPWH
$46.4M
$57K ﹤0.01%
13,000
-300
-2% -$1.46K
AUY
3349
DELISTED
Yamana Gold, Inc.
AUY
$55K ﹤0.01%
23,399
-400
-2% -$933
DSE
3350
DELISTED
Duff & Phelps Select MLP and Midstream Energy Fund Inc.
DSE
$55K ﹤0.01%
1,410
-940
-40% -$48.1K

Similar funds

Raymond James & Associates's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James & Associates held 3,843 positions worth $57.4B, down 11% from $64.7B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q4 2018 filing shows 205 new, 1,398 increased, 1,819 reduced and 309 closed positions. Its largest new stake was Linde: 549,404 shares worth $87.1M. The largest sale was Oracle, an estimated $124M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2018 buy was Linde: 549,404 shares worth $87.1M.
  • Raymond James & Associates added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $368M increase.
  • Raymond James & Associates's biggest Q4 2018 reduction was Oracle, cutting an estimated $124M.
  • Raymond James & Associates fully exited Praxair Inc in Q4 2018, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $57.4B portfolio in Q4 2018.
  • Raymond James & Associates opened 205 new positions and closed 309 in Q4 2018.
  • Raymond James & Associates's portfolio value fell 11% quarter-over-quarter to $57.4B.

Based on Raymond James & Associates's 13F filing for Q4 2018, filed 11 Feb 2019.